Kowalsky Matthew Paul (CIK 1705824) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy ENTA (1,318 shares), Buy ENTA (4,175 shares), Sell ENTA (1,902 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Legal Officer | Buy | 1,318 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Legal Officer | Buy | 4,175 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Legal Officer | Sell | 1,902 | $27,104 |
Source: SEC Form 4 filings · as of 2026-02-13